Items where Author is "Soroosh, S."
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 1.
(2022) Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia (R)) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial. ARTHRITIS RESEARCH & THERAPY. ISSN 1478-6354 1478-6362 J9 - ARTHRITIS RES THER